Abstract
Paraneoplastic syndromes are caused by systemic factors that are produced at a site distant from the primary tumor or its metastases. Although these syndromes can be observed in a variety of tumor types, they are commonly found in lung cancer, particularly small cell lung cancer. In this review, we focus on recent advances in the diagnosis and treatment of two of the more well-documented paraneoplastic syndromes--endocrinologic and neurologic systemic manifestations of cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
